New details about the critical decision to purchase spinal steroids from a Massachusetts drug compounding company have emerged in lawsuits filed on behalf of three local victims of the nationwide fungal meningitis outbreak.
In a motion filed Monday in circuit court in Nashville, attorneys for the victims charged that lawyers for the Saint Thomas Outpatient Neurosurgical Center were maneuvering to delay depositions of the key individuals involved in the decision to purchase methylprednisolone acetate from the now-closed New England Compounding Center.
continue reading here
No comments:
Post a Comment